Handle with appropriate laboratory precautions.
This is critical in reducing the risk of obesity-related conditions, such as heart disease, stroke, and type 2 diabetes
Due to GPhC requirements, you cannot add the medication to your basket here
While Retatrutide has not yet received Health Canada approval as a prescription medication (expected 2026-2027), it is available as a research peptide from Canadian suppliers
Compounded GLP-1 medications are prescribed only when a licensed healthcare provider determines, based on an individual patients medical needs, that an FDA-approved drug is not appropriate or that a clinically significant difference exists, such as dosage form, strength, or excipient composition
Book an appointment with one of our board-certified primary care doctors to discuss options for your weight loss journey, including brand name GLP-1 and compounded semaglutide if you cannot access brand name medications